In 2023, the Delaware courts made significant decisions implicating different areas of intellectual property (IP) and corporate law. These rulings addressed topics such as induced infringement of drug patents, special purpose acquisition company (SPAC) transactions, inter partes reviews (IPRs), and litigation funding disclosures.
In the recorded presentation, we review these rulings, anticipate their impact on future proceedings, and closely monitor developments in this year's cases.
Watch the video here or below:
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.